Deerfield Imaging (Minneapolis, MN) received FDA green light to introduce its SYMBIS stereotactic brain biopsy system in the U.S. The robotic system allows for a biopsy to be performed while the patient is inside an MRI scanner, with the goal being improved targeting and faster procedure times. Being able to visualize the target while working toward reaching it can significantly improve tissue sampling, hopefully also reducing repeat biopsies.
Since IMRIS, a part of Deerfield Imaging, produces intra-op MRIs, the SYMBIS biopsy robot nicely fits in with the company’s existing product line.
The company has plans to use the SYMBIS robot as a platform to build other tools for varying neurosurgical and maybe even other applications.
Regarding the FDA clearance, Deerfield Imaging President and CEO Jay D. Miller said, “Developing a new image-guided neurosurgical robot is a big undertaking with many challenges. This is a major milestone and the result of commitment from our team to produce core technology upon which we believe future neurosurgical applications beyond biopsy can be built.”
Source: Deerfield Imaging…